首页> 外文会议>IEEE International Ultrasonics Symposium >In vivo attenuation estimation in human thyroid nodules using the regularized spectral log difference technique: Initial pilot study
【24h】

In vivo attenuation estimation in human thyroid nodules using the regularized spectral log difference technique: Initial pilot study

机译:使用常规光谱对数差异技术估算人甲状腺结节的体内衰减:初步试验研究

获取原文

摘要

In vivo estimation of attenuation coefficients is useful because of its potential for tissue characterization and relevance in accurate backscatter coefficient estimation. However, current methods based on spectral analysis for ultrasonic attenuation estimation suffer from a severe trade-off between estimation precision and spatial resolution. Recently, the regularized spectral log difference (RSLD) technique was proposed to extend such trade-off in attenuation coefficient slope (ACS) estimation. The RSLD technique has been tested with simulated data and physical phantoms. Therefore, the aim of this pilot study is to validate the feasibility of in vivo estimation of ACSs from thyroid nodules using the RSLD technique.
机译:体内衰减系数的估计是有用的,因为它具有组织表征的潜力以及在精确的反向散射系数估计中的相关性。然而,当前基于频谱分析的用于超声衰减估计的方法在估计精度和空间分辨率之间存在严重的权衡。最近,提出了正则化频谱对数差(RSLD)技术来扩展衰减系数斜率(ACS)估计中的这种折衷。 RSLD技术已通过模拟数据和物理模型进行了测试。因此,该初步研究的目的是验证使用RSLD技术从甲状腺结节体内评估ACS的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号